Trial reportClinical rheumatology2025
Test the reliability and comparability of the paper version and electronic version of the Western Ontario and McMaster University Osteoarthritis Index in Chinese language: a randomized, cross-sectional study.
Trial report in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Neuromuscular exercise combined with pain neuroscience education for knee osteoarthritis management in older women: protocol for a randomized controlled trial.Journal of orthopaedic surgery and research · 2026Article
- Cross-Cultural Adaptation and Validation of the Kazakh Version of the WOMAC Index in Patients with Knee Osteoarthritis.International journal of environmental research and public health · 2026Article
- The Psychometric Properties of the Cone Evasion Walk Test in Patients With Knee Osteoarthritis.Occupational therapy international · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe electronic Western Ontario and McMaster University Osteoarthritis Index (e-WOMAC) is widely used for clinical evaluation of joint diseases. However, its validation and application in China remain limited. This study aimed to test and compare the reliability and comparability of the paper version (p-WOMAC) and electronic version (e-WOMAC) of WOMAC in Chinese patients with knee osteoarthritis (KOA).
objectiveThe study aims to provide valuable evidence on the feasibility and reliability of using electronic assessment tools to evaluate knee osteoarthritis (KOA) in the Chinese population through a rigorous evaluation of two versions of the WOMAC index.
methodsA total of 70 patients with KOA were recruited from the Orthopedic Outpatient Department of Shuguang Hospital and randomly assigned to group A or group B. Group A completed the p-WOMAC first, followed by e-WOMAC 15 min later, while group B completed the assessments in the reverse order. A cross-design analysis of variance, intraclass correlation coefficient (ICC) analysis, and Bland-Altman analysis were performed to compare the differences and consistency between the two versions.
resultsAmong the 70 participants, no significant demographic differences were observed between the groups (P > 0.05). The stage of administration and assessment method did not result in significant differences in individual or total scores between p-WOMAC and e-WOMAC (P > 0.05). Both formats demonstrated excellent reliability, with ICC values exceeding 0.96 for all subscales (pain, stiffness, and function). The Bland-Altman analysis showed that the absolute differences between p-WOMAC and e-WOMAC scores were within acceptable ranges: 12.4 for total score, 3.7 for pain, 1.49 for stiffness, and 10.2 for function, with mean differences of - 1.5, - 0.3, - 0.18, and - 1.0, respectively. Only a small proportion of participants (2.86% to 5.71%) had scores outside the 95% limits of agreement (LoA).
conclusionsThis study confirms the reliability and equivalence of the e-WOMAC compared to the p-WOMAC in Chinese patients with KOA, supporting its use in clinical management and research. Key Points • First validation of the Chinese e-WOMAC confirms equivalence to the paper version in KOA patients, addressing a critical digital health gap in China. • High patient preference for e-WOMAC underscores its feasibility for clinical integration, aligning with global digital healthcare advancements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.